Indicated therapy | Total | p | ||
Recurrent | Non-recurrent | |||
First-line therapy | 4 (25.0%) |
12 (75.0%) |
16 (100.0%) |
0.765 |
Second-line therapy | 0 (0.0%) |
1 (100.0%) |
17 (100.0%) |
|
Total | 4 (23.5%) |
13 (76.5%) |
17 (100.0%) |